BioCurex, Inc.(fka BOCX)

[bocxman]

We're back to the same place. While he has childishly repeated the point about 10 times, Kag refuses to explain why personalized baseline levels are required for a general screening test. While a persnoalized test is a nice application, it is not part and parcel with a general screening test. He also refuses to address the fact that every other general screening test on the market has been implemented without personalized baseline levels. Finally, he refuses to address the fact that BOCX has shown us RAW data which shows a universally applicable baseline level of RECAF.

Kag...sell your 150 shares and stop worrying about these ridiculous things. If you want to worry about something:

1) independant validation
2) ability to integrate on Architect
3) getting off the pink sheets